NeoGenomics NEO Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about NeoGenomics's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NeoGenomics's common stock, shares authorized (in shares)?
- NeoGenomics (NEO) reported common stock, shares authorized (in shares) of $250M in Q1 2026.
- How has NeoGenomics's common stock, shares authorized (in shares) changed year-over-year?
- NeoGenomics's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $250M to $250M.